Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced AnemiaRalph V. Boccia, Peter T. Silberstein, Imtiaz A. Malik et al.|The Oncologist|2006Cited by 40
The Effectiveness of Darbepoetin Alfa Administered Every 3 Weeks on Hematologic Outcomes and Quality of Life in Older Patients With Chemotherapy-Induced AnemiaRalph V. Boccia, Lodovico Balducci, Dianne Tomita et al.|The Oncologist|2007Cited by 16
1120 POSTER Evaluation of the association between hemoglobin (Hb) events and safety outcomes in cancer patients (pts) with chemotherapy-induced anemia (CIA): an integrated analysis of patient-level data from 6 randomized, placebo-controlled trials (RCTs) of darbepoetin alfa (DA)John A. Glaspy, J. Crawford, A. Fleishman et al.|European Journal of Cancer Supplements|2007Cited by 13
1104 POSTER Patient-level integrated analysis of data from 6 randomized, double-blind, placebo-controlled trials of darbepoetin alfa (DA) in patients (pts) with chemotherapy-induced anemia (CIA)H. Ludwig, John A. Glaspy, J. Crawford et al.|European Journal of Cancer Supplements|2007Cited by 3